Video
Catch up on the exciting Aesthetic Society and Aesthetic Foundation accomplishments and advances that took place in 2024.
The Aesthetic Society and The Aesthetic Foundation Year in Review 2024
Related Articles
This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
In this month’s update, Dr. Tracy Pfeifer highlights all the doctors who volunteer to help surgeons reach their goals, being up to date on cybersecurity, and the upcoming The MEET 2026 in Boston!
In this study, 11 patients were injected with Volbella XC into the tear trough region and subsequently underwent undereye volumetric measurements over a 90-day period.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
In this update, Dr. Pfeifer talks about the upcoming program planning for Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida, and The Aesthetic MEET in Boston, Massachusetts, recapping the May Master Class with Dr. Calobrace, and her upcoming trips to Monaco, New England, and Singapore!